Evolving Frontiers

The pharmaceutical and life sciences industry is entering a transformative phase, characterised by strategic realignment and long-term investment in innovation. As global demand grows for advanced therapies and sustainable production, major players are reconfiguring operations to enhance efficiency and scientific output.

SGS continues to empower professionals worldwide through its series of expert-led webinars, offering in-depth insights into evolving regulatory expectations, analytical testing challenges, and global industry best practices. 

The US Food and Drug Administration (FDA) has announced new measures to accelerate the approval of biosimilar medicines, generic versions of complex biologics engineered from living cells, marking a major shift in the pharmaceutical landscape.

Meanwhile, Kuehne+Nagel named title sponsor for Pharma Industry Awards 2025 highlights how collaboration between healthcare logistics and life sciences continues to strengthen sector-wide innovation and recognition.

These developments illustrate an industry balancing progress with precision, advancing innovation while ensuring global access and operational excellence.

Stay connected to the ideas shaping the future of pharma, explore the full stories in this edition of our newsletter.